
Browsing restrictions can be lifted for a fee.
Ocular therapeutix, inc. (OCUL) 2025Q4 shows a mild decline in contract liabilities year-on-year. This slight decrease in new orders may be caused by delivery postponements, early revenue recognition, or shifts in external demand. Continued observation of new order momentum and industry conditions in coming quarters is recommended.